Adam J. Mead
Oxford Health NHS Foundation Trust(GB)John Radcliffe Hospital(GB)National Institute for Health Research(GB)University of Oxford(GB)MRC Weatherall Institute of Molecular Medicine(GB)MRC Human Immunology Unit(GB)Oxford BioMedica (United Kingdom)(GB)Oxford University Hospitals NHS Trust(GB)Medical Research Council(GB)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Kruppel-like factors research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia(2007)740 cited
- → Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia(2011)636 cited
- → Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy(2013)621 cited
- → Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia(2017)416 cited
- → Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells(2016)338 cited
- → FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia(2007)